Tags : FreeStyle Libre 2

MedTech Regulatory

Abbott’s FreeStyle Libre 2 Receives Health Canada’s Approval for Adults

Shots: Abbott’s next-generation, sensor-based glucose monitoring technology, FreeStyle Libre 2, received Health Canada’s approval for adults & children with diabetes The system continuously measures glucose data every minute with customizable, optional real-time alarms to alert users when their glucose is high/low without scanning The technology sustains performance for ~14days, providing trends, insights & actionable data […]Read More